1 / 5

Ovarian Cancer Therapeutics in APAC Market Forecast & Future Industry Trends

Ovarian Cancer Therapeutics in APAC Market covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Ovarian Cancer (OC).

MIR114
Télécharger la présentation

Ovarian Cancer Therapeutics in APAC Market Forecast & Future Industry Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ovarian Cancer Therapeutics in Asia- Pacific Markets to 2020- Off- patent Chemo- regimens to Retain Dominance Despite New Launches Published on – 31 January, 2015 | Number of pages : 126 Single User Price: $4995 “Ovarian CnacerTherapeutics market in APAC is expected not be driven by new drug approvals, but primarily by inflation, and the increase in the prevalence of OC. Market revenue is forecast to rise at a limited CAGR of 5.1% to $417.6m in 2020.”

  2. Summary of the Report:MarketIntelReports Research, a leading business intelligence provider, has released its latest research report, "Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches". The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, China, Australia and Japan. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of clinical trials including failure rates and pipeline analysis, and analysis of deals relevant to Ovarian Cancer (OC). Platinum-based chemotherapy, predominantly the chemotherapy regimen paclitaxel and carboplatin, is the standard of care for the treatment of platinum-sensitive OC (both first-line and recurrent). The initial treatment is quite effective, with the majority of patients entering remission. However, almost all relapse, and after successive periods of remission and relapse either die or progress to platinum-resistant disease, for which the prognosis is poor. There is a clear gap in the market for maintenance therapies, as well as for more effective treatment options in platinum-resistant or refractory patients. Click Here To Check Complete Report

  3. Scope of the Report: • The report analyzes treatment usage patterns, drug types available and pipeline and market forecasts for OC. It covers and includes - • A brief introduction to OC, including the disease’s pathogenesis, risk factors and diagnosis • In-depth analysis of the drug combinations used in the treatment of OC, including analyses of their safety, efficacy, and place in the disease treatment algorithm, as well as a heat map comparing the drug combinations in terms of safety and efficacy • A comprehensive review of the pipeline for OC therapies, including individual analysis of a number of late-stage pipeline drugs that have the potential to enter the market in the forecast period; the pipeline is analyzed on the basis of phase distribution, molecule type and molecular target, and route of administration • Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type, trial size, and trial duration, and program failure rate analyses for each molecule type and mechanism of action Download Sample Brochure

  4. Reasons to Buy: • The report will assist business development and enable marketing executives to strategize their product launches, by allowing them to - • Understand the efficacy and safety of the current monotherapies and drug combinations used in the treatment of OC, with in-depth analysis of the disease treatment algorithm • Understand the key signaling pathways and molecular targets currently under investigation in OC drug development • Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent • Observe the trends in clinical trial duration and size among clinical phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for OC therapeutics • Assess the potential clinical and commercial impact of current late-stage pipeline molecules in the OC therapeutics market Make an Inquiry Before Buying

  5. Ovarian Cancer Therapeutics in Asia- Pacific Markets to 2020- Off- patent Chemo- regimens to Retain Dominance Despite New Launches A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Ovarian Cancer Therapeutics in Asia- Pacific Market are provided in the report. Contact: 1-302-684-6088 sales@marketintelreports.com www.marketintelreports.com Click here to order a copy of Ovarian Cancer Therapeutics in Asia- Pacific Market Report

More Related